Characterization of a complement-binding protein, DRS, from strains of Streptococcus pyogenes containing the emm12 and emm55 genes

被引:17
作者
Binks, M [1 ]
Sriprakash, KS [1 ]
机构
[1] Queensland Inst Med Res, Brisbane, Qld, Australia
关键词
D O I
10.1128/IAI.72.7.3981-3986.2004
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
An extracellular protein of Streptococcus pyogenes, streptococcal inhibitor of complement (SIC), and its variant, called DRS (distantly related to SIC), are expressed by some S. pyogenes strains. SIC from type 1 (M1) isolates of S. pyogenes interferes with complement-mediated cell lysis, reportedly via its interaction with complement proteins. In this study we demonstrate that S. pyogenes strains carrying emm12 and emm55 (the genes for the M12 and M55 proteins, respectively) express and secrete DRS. This protein, like SIC, binds to the C6 and C7 complement proteins, and competition enzyme-linked immunosorbent assay experiments demonstrate that DRS competes with SIC for C6 and C7 binding. Similarly, SIC competes with DRS for binding to the complement proteins. Despite this, the recombinant DRS preparation showed no significant effect on complement function, as determined by lysis of sensitized sheep erythrocytes. Furthermore, the presence of DRS is not inhibitory to SIC activity.
引用
收藏
页码:3981 / 3986
页数:6
相关论文
共 35 条
[1]   Protein SIC, a novel extracellular protein of Streptococcus pyogenes interfering with complement function [J].
Akesson, P ;
Sjoholm, AG ;
Bjorck, L .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (02) :1081-1088
[2]   Genomic location and variation of the gene for CRS, a complement binding protein in the M57 strains of Streptococcus pyogenes [J].
Binks, M ;
McMillan, D ;
Sriprakash, KS .
INFECTION AND IMMUNITY, 2003, 71 (12) :6701-6706
[3]   Characterization of consecutive Streptococcus pyogenes isolates from patients with pharyngitis and bacteriological treatment failure:: Special reference to prtF1 and sic/drs [J].
Brandt, CM ;
Allerberger, F ;
Spellerberg, B ;
Holland, R ;
Lütticken, R ;
Haase, G .
JOURNAL OF INFECTIOUS DISEASES, 2001, 183 (04) :670-674
[4]   Genetic relatedness and superantigen expression in group A streptococcus serotype MZ isolates from patients with severe and nonsevere invasive diseases [J].
Chatellier, S ;
Ihendyane, N ;
Kansal, RG ;
Khambaty, F ;
Basma, H ;
Norrby-Teglund, A ;
Low, DE ;
McGeer, A ;
Kotb, M .
INFECTION AND IMMUNITY, 2000, 68 (06) :3523-3534
[5]   Immunohistochemical and serological evidence for the role of streptococcal proteinase in acute post-streptococcal glomerulonephritis [J].
Cu, GA ;
Mezzano, S ;
Bannan, JD ;
Zabriskie, JB .
KIDNEY INTERNATIONAL, 1998, 54 (03) :819-826
[6]   Pathogenesis of group A streptococcal infections [J].
Cunningham, MW .
CLINICAL MICROBIOLOGY REVIEWS, 2000, 13 (03) :470-+
[7]  
Dedeoglu IO, 1996, CLIN NEPHROL, V46, P302
[8]  
DILLON HC, 1979, REV INFECT DIS, V1, P935
[9]   Streptococcal inhibitor of complement inhibits two additional components of the mucosal innate immune system: Secretory leukocyte proteinase inhibitor and lysozyme [J].
Fernie-King, BA ;
Seilly, DJ ;
Davies, A ;
Lachmann, PJ .
INFECTION AND IMMUNITY, 2002, 70 (09) :4908-4916
[10]   Streptococcal inhibitor of complement (SIC) inhibits the membrane attack complex by preventing uptake of C567 onto cell membranes [J].
Fernie-King, BA ;
Seilly, DJ ;
Willers, C ;
Würzner, R ;
Davies, A ;
Lachmann, PJ .
IMMUNOLOGY, 2001, 103 (03) :390-398